GlobeNewswire: GeneNews Limited Contains the last 10 of 94 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T03:51:43ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2016/11/11/889223/0/en/GeneNews-Announces-Q3-2016-Financial-Results-and-Provides-Corporate-Update.html?f=22&fvtc=4&fvtv=14056GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update2016-11-11T12:30:00Z<![CDATA[TORONTO, Nov. 11, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month period ended September 30, 2016.]]>https://www.globenewswire.com/news-release/2016/10/03/876511/0/en/GeneNews-Provides-Update-on-GEM-and-Alumina-Financings.html?f=22&fvtc=4&fvtv=14056GeneNews Provides Update on GEM and Alumina Financings2016-10-03T12:00:00Z<![CDATA[TORONTO, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Further to its press releases issued on April 28, June 9 and July 26, 2016, GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) provided an update today on its financing activities.]]>https://www.globenewswire.com/news-release/2016/09/19/872975/0/en/Director-Increases-Ownership-in-GeneNews-Limited.html?f=22&fvtc=4&fvtv=14056Director Increases Ownership in GeneNews Limited2016-09-19T21:00:00Z<![CDATA[TORONTO, Sept. 19, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited: Mr. Rory Riggs, a director of GeneNews Limited (“GeneNews”) (TSX:GEN), announces that, pursuant to a private placement which took place on September 1, 2016 (the “Private Placement”), he, as an individual, personally acquired 2,500,00 units (“Units”) of GeneNews.  Each Unit is comprised of one common share (“Common Share”) and one-quarter of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”).  Each Warrant will entitle the holder to acquire one common share (a “Warrant Share”) at a price per Warrant Share of CAD $0.50 for a period ending August 15, 2018.]]>https://www.globenewswire.com/news-release/2016/09/19/872782/0/en/GeneNews-and-NueHealth-Announce-Partnership-in-Early-Cancer-Diagnostics.html?f=22&fvtc=4&fvtv=14056GeneNews and NueHealth Announce Partnership in Early Cancer Diagnostics2016-09-19T11:30:00Z<![CDATA[- NueHealth Patients Now Have Access to Advanced Early Cancer Detection Tests - - NueHealth Patients Now Have Access to Advanced Early Cancer Detection Tests -]]>https://www.globenewswire.com/news-release/2016/09/02/869194/0/en/GeneNews-Closes-Private-Placement-for-Approximately-1-6-Million.html?f=22&fvtc=4&fvtv=14056GeneNews Closes Private Placement for Approximately $1.6 Million2016-09-02T12:45:00Z<![CDATA[THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.]]>https://www.globenewswire.com/news-release/2016/08/11/863539/0/en/GeneNews-Announces-Q2-2016-Financial-Results.html?f=22&fvtc=4&fvtv=14056GeneNews Announces Q2-2016 Financial Results2016-08-11T11:45:00Z<![CDATA[TORONTO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month and six-month periods ended June 30, 2016.]]>https://www.globenewswire.com/news-release/2016/07/26/859088/0/en/GeneNews-Provides-Financing-Update.html?f=22&fvtc=4&fvtv=14056GeneNews Provides Financing Update2016-07-26T20:30:00Z<![CDATA[TORONTO, July 26, 2016 (GLOBE NEWSWIRE) -- Further to its press releases issued on December 7, 2015 and June 9, 2016, GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) provided an update today on its financing activities.]]>https://www.globenewswire.com/news-release/2016/06/30/852943/0/en/GeneNews-Announces-Election-of-Directors.html?f=22&fvtc=4&fvtv=14056GeneNews Announces Election of Directors2016-06-30T22:30:00Z<![CDATA[TORONTO, June 30, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today announced that all of the nominee directors listed in the Company’s management information circular dated May 27, 2016, were elected as directors of the Company. The vote was conducted at the Company's annual and special meeting of shareholders held on June 30, 2016. The results of the vote are set out below:]]>https://www.globenewswire.com/news-release/2016/06/16/849152/0/en/GeneNews-Meets-TSX-Continued-Listing-Requirements.html?f=22&fvtc=4&fvtv=14056GeneNews Meets TSX Continued Listing Requirements2016-06-16T14:30:00Z<![CDATA[TORONTO, June 16, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) is pleased to announce that the Toronto Stock Exchange ("TSX") has completed its Remedial Review Process and determined that the Company meets the TSX's continued listing requirements. ]]>https://www.globenewswire.com/news-release/2016/06/16/849061/0/en/GeneNews-MCTO-Lifted.html?f=22&fvtc=4&fvtv=14056GeneNews MCTO Lifted2016-06-16T11:30:00Z<![CDATA[TORONTO, June 16, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) announced today that the Management Cease Trade Order (“MCTO”) imposed by the Ontario Securities Commission (“OSC”) has been lifted. With this resolution of the MCTO, members of management are no longer precluded from trading the Company’s common shares.]]>